Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 76

1.

Bacterial Infections Associated with Substance Use Disorders, Large Cohort of United States Hospitals, 2012-2017.

Mccarthy NL, Baggs J, See I, Reddy SC, Jernigan JA, Gokhale RH, Fiore AE.

Clin Infect Dis. 2020 Jan 7. pii: ciaa008. doi: 10.1093/cid/ciaa008. [Epub ahead of print]

PMID:
31907515
2.

A National Approach to Pediatric Sepsis Surveillance.

Hsu HE, Abanyie F, Agus MSD, Balamuth F, Brady PW, Brilli RJ, Carcillo JA, Dantes R, Epstein L, Fiore AE, Gerber JS, Gokhale RH, Joyner BL Jr, Kissoon N, Klompas M, Lee GM, Macias CG, Puopolo KM, Sulton CD, Weiss SL, Rhee C.

Pediatrics. 2019 Dec;144(6). pii: e20191790. doi: 10.1542/peds.2019-1790.

PMID:
31776196
3.

Variation in Identifying Sepsis and Organ Dysfunction Using Administrative Versus Electronic Clinical Data and Impact on Hospital Outcome Comparisons.

Rhee C, Jentzsch MS, Kadri SS, Seymour CW, Angus DC, Murphy DJ, Martin GS, Dantes RB, Epstein L, Fiore AE, Jernigan JA, Danner RL, Warren DK, Septimus EJ, Hickok J, Poland RE, Jin R, Fram D, Schaaf R, Wang R, Klompas M; Centers for Disease Control and Prevention (CDC) Prevention Epicenters Program.

Crit Care Med. 2019 Apr;47(4):493-500. doi: 10.1097/CCM.0000000000003554.

PMID:
30431493
4.

Assessing Variability in Hospital-Level Mortality Among U.S. Medicare Beneficiaries With Hospitalizations for Severe Sepsis and Septic Shock.

Hatfield KM, Dantes RB, Baggs J, Sapiano MRP, Fiore AE, Jernigan JA, Epstein L.

Crit Care Med. 2018 Nov;46(11):1753-1760. doi: 10.1097/CCM.0000000000003324.

5.

Antimicrobial Efficacy of a New Chlorhexidine-based Device Against Staphylococcus aureus Colonization of Venous Catheters.

Kowalewska PM, Petrik SM, Di Fiore AE, Fox-Robichaud AE.

J Infus Nurs. 2018 Mar/Apr;41(2):103-112. doi: 10.1097/NAN.0000000000000267.

6.

Incidence and Trends of Sepsis in US Hospitals Using Clinical vs Claims Data, 2009-2014.

Rhee C, Dantes R, Epstein L, Murphy DJ, Seymour CW, Iwashyna TJ, Kadri SS, Angus DC, Danner RL, Fiore AE, Jernigan JA, Martin GS, Septimus E, Warren DK, Karcz A, Chan C, Menchaca JT, Wang R, Gruber S, Klompas M; CDC Prevention Epicenter Program.

JAMA. 2017 Oct 3;318(13):1241-1249. doi: 10.1001/jama.2017.13836.

7.

The Potential for Interventions in a Long-term Acute Care Hospital to Reduce Transmission of Carbapenem-Resistant Enterobacteriaceae in Affiliated Healthcare Facilities.

Toth DJA, Khader K, Slayton RB, Kallen AJ, Gundlapalli AV, O'Hagan JJ, Fiore AE, Rubin MA, Jernigan JA, Samore MH.

Clin Infect Dis. 2017 Aug 15;65(4):581-587. doi: 10.1093/cid/cix370.

PMID:
28472233
8.

2013 multistate outbreaks of Cyclospora cayetanensis infections associated with fresh produce: focus on the Texas investigations.

Abanyie F, Harvey RR, Harris JR, Wiegand RE, Gaul L, Desvignes-Kendrick M, Irvin K, Williams I, Hall RL, Herwaldt B, Gray EB, Qvarnstrom Y, Wise ME, Cantu V, Cantey PT, Bosch S, DA Silva AJ, Fields A, Bishop H, Wellman A, Beal J, Wilson N, Fiore AE, Tauxe R, Lance S, Slutsker L, Parise M; Multistate Cyclosporiasis Outbreak Investigation Team.

Epidemiol Infect. 2015 Dec;143(16):3451-8. doi: 10.1017/S0950268815000370. Epub 2015 Apr 13.

9.

Toxocariasis: A Review for Pediatricians.

Woodhall DM, Fiore AE.

J Pediatric Infect Dis Soc. 2014 Jun;3(2):154-9. doi: 10.1093/jpids/pit066. Epub 2013 Oct 31. Review.

PMID:
26625368
10.

Neglected parasitic infections in the United States: toxoplasmosis.

Jones JL, Parise ME, Fiore AE.

Am J Trop Med Hyg. 2014 May;90(5):794-799. doi: 10.4269/ajtmh.13-0722.

11.

Effects of vaccine program against pandemic influenza A(H1N1) virus, United States, 2009-2010.

Borse RH, Shrestha SS, Fiore AE, Atkins CY, Singleton JA, Furlow C, Meltzer MI.

Emerg Infect Dis. 2013 Mar;19(3):439-48. doi: 10.3201/eid1903.120394.

12.

Expanding the recommendations for annual influenza vaccination to school-age children in the United States.

Fiore AE, Epperson S, Perrotta D, Bernstein H, Neuzil K.

Pediatrics. 2012 Mar;129 Suppl 2:S54-62. doi: 10.1542/peds.2011-0737C.

PMID:
22383482
13.

Evolution of the pediatric influenza vaccination program in the United States.

Neuzil KM, Fiore AE, Schieber RA.

Pediatrics. 2012 Mar;129 Suppl 2:S51-3. doi: 10.1542/peds.2011-0737B. No abstract available.

PMID:
22383481
14.

Antiviral treatment of influenza in children.

Garg S, Fry AM, Patton M, Fiore AE, Finelli L.

Pediatr Infect Dis J. 2012 Feb;31(2):e43-51. doi: 10.1097/INF.0b013e31824671ab. Review.

PMID:
22252215
15.

Community-based values for 2009 pandemic influenza A H1N1 illnesses and vaccination-related adverse events.

Lavelle TA, Meltzer MI, Gebremariam A, Lamarand K, Fiore AE, Prosser LA.

PLoS One. 2011;6(12):e27777. doi: 10.1371/journal.pone.0027777. Epub 2011 Dec 19.

16.

Cost-effectiveness of 2009 pandemic influenza A(H1N1) vaccination in the United States.

Prosser LA, Lavelle TA, Fiore AE, Bridges CB, Reed C, Jain S, Dunham KM, Meltzer MI.

PLoS One. 2011;6(7):e22308. doi: 10.1371/journal.pone.0022308. Epub 2011 Jul 29.

17.

Antiviral agents for the treatment and chemoprophylaxis of influenza --- recommendations of the Advisory Committee on Immunization Practices (ACIP).

Fiore AE, Fry A, Shay D, Gubareva L, Bresee JS, Uyeki TM; Centers for Disease Control and Prevention (CDC).

MMWR Recomm Rep. 2011 Jan 21;60(1):1-24.

18.

Completion of the 2-dose influenza vaccine series among children aged 6 to 59 months: immunization information system sentinel sites, 2007-2008 influenza season.

Pabst LJ, Fiore AE, Cullen KA.

Clin Pediatr (Phila). 2011 Nov;50(11):1068-70. doi: 10.1177/0009922810385928. Epub 2010 Nov 22. No abstract available.

PMID:
21098532
19.

Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010.

Fiore AE, Uyeki TM, Broder K, Finelli L, Euler GL, Singleton JA, Iskander JK, Wortley PM, Shay DK, Bresee JS, Cox NJ; Centers for Disease Control and Prevention (CDC).

MMWR Recomm Rep. 2010 Aug 6;59(RR-8):1-62. Erratum in: MMWR Recomm Rep. 2010 Aug 13;59(31):993. MMWR Recomm Rep. 2010 Sep 10;59(35):1147.

20.

Antiviral treatment of patients with oseltamivir-resistant and oseltamivir-susceptible seasonal Influenza A (H1N1) infection during the 2007-2008 influenza season in the United States.

Dharan NJ, Gubareva LV, Klimov AI, Fiore AE, Bresee JS, Fry AM.

Clin Infect Dis. 2010 Feb 15;50(4):621-2. doi: 10.1086/650178. No abstract available.

PMID:
20095841
21.

2009 influenza A(H1N1) monovalent vaccines for children.

Fiore AE, Neuzil KM.

JAMA. 2010 Jan 6;303(1):73-4. doi: 10.1001/jama.2009.1929. Epub 2009 Dec 21. No abstract available.

PMID:
20026596
22.

Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009.

Jain S, Kamimoto L, Bramley AM, Schmitz AM, Benoit SR, Louie J, Sugerman DE, Druckenmiller JK, Ritger KA, Chugh R, Jasuja S, Deutscher M, Chen S, Walker JD, Duchin JS, Lett S, Soliva S, Wells EV, Swerdlow D, Uyeki TM, Fiore AE, Olsen SJ, Fry AM, Bridges CB, Finelli L; 2009 Pandemic Influenza A (H1N1) Virus Hospitalizations Investigation Team.

N Engl J Med. 2009 Nov 12;361(20):1935-44. doi: 10.1056/NEJMoa0906695. Epub 2009 Oct 8.

23.

A primer on strategies for prevention and control of seasonal and pandemic influenza.

SantibaƱez S, Fiore AE, Merlin TL, Redd S.

Am J Public Health. 2009 Oct;99 Suppl 2:S216-24. doi: 10.2105/AJPH.2009.164848.

24.

Antibody levels and protection after hepatitis B vaccine: results of a 22-year follow-up study and response to a booster dose.

McMahon BJ, Dentinger CM, Bruden D, Zanis C, Peters H, Hurlburt D, Bulkow L, Fiore AE, Bell BP, Hennessy TW.

J Infect Dis. 2009 Nov 1;200(9):1390-6. doi: 10.1086/606119.

PMID:
19785526
25.

Seasonal influenza vaccines.

Fiore AE, Bridges CB, Cox NJ.

Curr Top Microbiol Immunol. 2009;333:43-82. doi: 10.1007/978-3-540-92165-3_3. Review.

PMID:
19768400
26.

Reduction in hepatitis B virus seroprevalence among U.S.-born children of foreign-born Asian parents -- benefit of universal infant hepatitis B vaccination.

Shuler CM, Fiore AE, Neeman R, Bell BP, Kuhnert W, Watkins S, Kilgour K, Arnold KE.

Vaccine. 2009 Oct 9;27(43):5942-7. doi: 10.1016/j.vaccine.2009.07.087. Epub 2009 Aug 11.

PMID:
19679217
27.

Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009.

Fiore AE, Shay DK, Broder K, Iskander JK, Uyeki TM, Mootrey G, Bresee JS, Cox NJ; Centers for Disease Control and Prevention.

MMWR Recomm Rep. 2009 Jul 31;58(RR-8):1-52. Erratum in: MMWR Recomm Rep. 2009 Aug 21;58(32):896-7.

28.

Overcoming challenges to influenza vaccination in patients with CKD.

Kallen AJ, Fiore AE.

Am J Kidney Dis. 2009 Jul;54(1):6-9. doi: 10.1053/j.ajkd.2009.04.007. No abstract available.

PMID:
19559336
29.

Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008.

Fiore AE, Shay DK, Broder K, Iskander JK, Uyeki TM, Mootrey G, Bresee JS, Cox NS; Centers for Disease Control and Prevention (CDC); Advisory Committee on Immunization Practices (ACIP).

MMWR Recomm Rep. 2008 Aug 8;57(RR-7):1-60.

30.

Preventing blood contamination in nuclear pharmacies: lessons from an outbreak of hepatitis C virus infections and contaminated 99mTc-sestamibi.

Patel PR, Perz JF, Fiore AE, Castel AD.

J Nucl Med. 2007 Nov;48(11):1911-2; author reply 1912. No abstract available.

31.

Hepatitis B immunity in children vaccinated with recombinant hepatitis B vaccine beginning at birth: a follow-up study at 15 years.

Hammitt LL, Hennessy TW, Fiore AE, Zanis C, Hummel KB, Dunaway E, Bulkow L, McMahon BJ.

Vaccine. 2007 Sep 28;25(39-40):6958-64. Epub 2007 Jul 17.

PMID:
17714836
32.

Comment and update on influenza prevention and treatment.

Fiore AE, Shay DK.

Clin Infect Dis. 2007 Sep 1;45(5):670-1. No abstract available.

PMID:
17683014
33.

Differences in response to a hepatitis B vaccine booster dose among Alaskan children and adolescents vaccinated during infancy.

Samandari T, Fiore AE, Negus S, Williams JL, Kuhnert W, McMahon BJ, Bell BP.

Pediatrics. 2007 Aug;120(2):e373-81. Epub 2007 Jul 16.

PMID:
17636112
34.

Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2007.

Fiore AE, Shay DK, Haber P, Iskander JK, Uyeki TM, Mootrey G, Bresee JS, Cox NJ; Advisory Committee on Immunization Practices (ACIP), Centers for Disease Control and Prevention (CDC).

MMWR Recomm Rep. 2007 Jul 13;56(RR-6):1-54.

35.

Missed opportunities for the prevention of influenza.

Fiore AE, Wortley PM, Bridges CB.

Prev Med. 2007 Jul;45(1):88-9. Epub 2007 May 21. No abstract available.

PMID:
17559917
36.

Use of molecular epidemiology to confirm a multistate outbreak of hepatitis A caused by consumption of oysters.

Bialek SR, George PA, Xia GL, Glatzer MB, Motes ML, Veazey JE, Hammond RM, Jones T, Shieh YC, Wamnes J, Vaughan G, Khudyakov Y, Fiore AE.

Clin Infect Dis. 2007 Mar 15;44(6):838-40. Epub 2007 Feb 13.

PMID:
17304457
37.

Molecular confirmation of oysters as the vector for hepatitis A in a 2005 multistate outbreak.

Shieh YC, Khudyakov YE, Xia G, Ganova-Raeva LM, Khambaty FM, Woods JW, Veazey JE, Motes ML, Glatzer MB, Bialek SR, Fiore AE.

J Food Prot. 2007 Jan;70(1):145-50.

PMID:
17265873
38.

Immunogenicity of an inactivated hepatitis A vaccine in infants and young children.

Bell BP, Negus S, Fiore AE, Plotnik J, Dhotre KB, Williams J, Shapiro CN, McMahon BJ.

Pediatr Infect Dis J. 2007 Feb;26(2):116-22.

PMID:
17259872
39.

Cost-effectiveness of routine childhood vaccination for hepatitis A in the United States.

Rein DB, Hicks KA, Wirth KE, Billah K, Finelli L, Fiore AE, Hoerger TJ, Bell BP, Armstrong GL.

Pediatrics. 2007 Jan;119(1):e12-21.

PMID:
17200237
40.

A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) Part II: immunization of adults.

Mast EE, Weinbaum CM, Fiore AE, Alter MJ, Bell BP, Finelli L, Rodewald LE, Douglas JM Jr, Janssen RS, Ward JW; Advisory Committee on Immunization Practices (ACIP) Centers for Disease Control and Prevention (CDC).

MMWR Recomm Rep. 2006 Dec 8;55(RR-16):1-33; quiz CE1-4. Erratum in: MMWR Morb Mortal Wkly Rep. 2007 Oct 26;56(42):1114.

41.

Hepatitis C virus infections from a contaminated radiopharmaceutical used in myocardial perfusion studies.

Patel PR, Larson AK, Castel AD, Ganova-Raeva LM, Myers RA, Roup BJ, Farrell KP, Edwards L, Nainan O, Krick JP, Blythe D, Fiore AE, Roche JC.

JAMA. 2006 Oct 25;296(16):2005-11.

PMID:
17062864
42.

Near elimination of hepatitis B virus infections among Hawaii elementary school children after universal infant hepatitis B vaccination.

Perz JF, Elm JL Jr, Fiore AE, Huggler JI, Kuhnert WL, Effler PV.

Pediatrics. 2006 Oct;118(4):1403-8.

PMID:
17015529
43.

Hepatitis B virus infection: epidemiology and vaccination.

Shepard CW, Simard EP, Finelli L, Fiore AE, Bell BP.

Epidemiol Rev. 2006;28:112-25. Epub 2006 Jun 5. Review.

PMID:
16754644
44.

Prevention of hepatitis A through active or passive immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP).

Advisory Committee on Immunization Practices (ACIP), Fiore AE, Wasley A, Bell BP.

MMWR Recomm Rep. 2006 May 19;55(RR-7):1-23.

45.

What's next for the hepatitis A vaccine?

Rein DB, Fiore AE, Bell BP.

Lancet. 2006 Feb 18;367(9510):546-8. No abstract available.

PMID:
16488780
46.

Preventing the transmission of bloodborne viruses during glucose monitoring: lessons learned from recent outbreaks.

Perz JF, Fiore AE.

J Am Med Dir Assoc. 2006 Jan;7(1):65-6. Epub 2005 Nov 23. No abstract available.

PMID:
16413439
47.

Factors associated with hepatitis a vaccination among children 24 to 35 months of age: United States, 2003.

Amon JJ, Darling N, Fiore AE, Bell BP, Barker LE.

Pediatrics. 2006 Jan;117(1):30-3.

PMID:
16396857
48.

A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) part 1: immunization of infants, children, and adolescents.

Mast EE, Margolis HS, Fiore AE, Brink EW, Goldstein ST, Wang SA, Moyer LA, Bell BP, Alter MJ; Advisory Committee on Immunization Practices (ACIP).

MMWR Recomm Rep. 2005 Dec 23;54(RR-16):1-31. Erratum in: MMWR Morb Mortal Wkly Rep. 2006 Feb 17;55(6):158-9. MMWR Morb Mortal Wkly Rep. 2007 Dec 7;56(48):1267.

49.

Epidemiology of hepatitis B and hepatitis B virus infection in United States children.

Shepard CW, Finelli L, Fiore AE, Bell BP.

Pediatr Infect Dis J. 2005 Sep;24(9):755-60. Review.

PMID:
16148839
50.

An outbreak of hepatitis A associated with green onions.

Wheeler C, Vogt TM, Armstrong GL, Vaughan G, Weltman A, Nainan OV, Dato V, Xia G, Waller K, Amon J, Lee TM, Highbaugh-Battle A, Hembree C, Evenson S, Ruta MA, Williams IT, Fiore AE, Bell BP.

N Engl J Med. 2005 Sep 1;353(9):890-7.

Supplemental Content

Loading ...
Support Center